Genetic and pharmacological analysis of prostanoid receptor function

Journal of Clinical Investigation

Volumn 108, Issue 1, 2001, Pages 25-30

  Narumiya, S ^a   FitzGerald, G A ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

17 PHENYLPROSTAGLANDIN E2; 4 [3 [3 (3 HYDROXYOCTYL) 4 OXO 2 THIAZOLIDINYL]PROPYL]BENZOIC ACID; CARBACYCLIN; ICOSANOID; ILOPROST; ONO 8713; ONOAE 1259; ONOAE 248; ONOAE 329; PROSTAGLANDIN E2 DERIVATIVE; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ALLERGY; CARDIOVASCULAR EFFECT; HUMAN; IMMUNITY; KNOCKOUT MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASPIRIN; BIOLOGICAL TRANSPORT; BONE RESORPTION; CELL NUCLEUS; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DRUG DESIGN; FEMALE; FEVER; GTP-BINDING PROTEINS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; ISCHEMIA; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PAIN; PLACENTA; PREGNANCY; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION; THROMBOXANES; VASODILATION;

EID: 0034931501     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113455     Document Type: Review

References (49)

1. Regulated formation of eicosanoids
2. Prostanoid receptors: Structures, properties, and functions
3. Internalization and sequestration of the human prostacyclin receptor
4. 2α-III, induce cardiomyocyte hypertrophy: Differential activation of downstream signaling pathways
5. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
6. Inducible cyclooxygenase may have anti-inflammatory properties
7. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
8. 2 as a mediator of allergic asthma
9. Distinct and coordinated roles of prostaglandin H-synthesis 1 and 2 in T-cell development
10. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2
11. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes
12. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines in lipopolysaccharide
13. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice
14. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro
15. 2: Studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists
16. Why there are two cyclooxygenase isozymes
17. Role of prostaglandin E receptor subtype EP1 in colon carcinogenesis
18. Is cyclooxygenase-2 the alpha and the omega in cancer?
19. Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs
20. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2
21. Phosphorylation of the thromboxane receptor α, the predominant isoform expressed in human platelets
22. 2 receptor (TP) isoforms
23. Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation
24. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: Evidence that eicosanoids other dian thromboxane contribute to atherosclerosis
25. Salt-sensitivity hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
26. Reproductive failure and reduced blood pressure in mice lacking the E prostaglandin E2 receptor
27. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
28. Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: Studies using mice deficient in prostanoid receptors
29. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation
30. Systemic biosynthesis of prostacyclin by cyclooxygenase: The human pharmacology of a selective inhibitor of COX-2
31. Oxidative damage of cardiomyocytes is limited by extracellular regulate kinases 1/2-mediated induction of cyclooxygenase-2
32. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits
33. 2 is a ligand for the adipocyte determination factor PPARγ
34. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
35. 2, the peroxisome proliferator-activated receptor gamma ligand, in urine
36. 2 in nuclei
37. Cyclo-oxygenase-2-derives prostacyclin mediates embryo implantation in the mouse via PPARδ
38. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ)
39. 2 receptor gene
40. Abortive expansion of the cumulus and impaired fertility I mice lacking the prostaglandin E receptor subtype EP2
41. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2
42. Characterization of murine vasopressor and vasode-pressor prostaglandin E2 receptors
43. 2 in mice
44. Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E-receptor subtype EP3
45. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2
46. The prostaglandin receptor EP4 triggers remodeling of the cardiovascular system at birth
47. Patent ductus arteriosus and neonatal death in prostaglandin receptor deficient mice
48. Failure of parturition in mice lacking the prostaglandin F receptor
49. Intrinsic prostacyclin contributes to exudation induced by bradykinin or car rageenin: A study on the paw edema induced in IP-receptor-deficient mice